HongKong:2373

BeautyFarm Med, the largest provider of traditional beauty services in China Successfully Listed on the Main Board of SEHK

Retrieved on: 
Tuesday, January 17, 2023
Joint, Motherboard, Marketing, Publicis Healthcare Communications Group, Neology, Stock exchange, HK, Joint Management Entrance Test, Property management

The stock price of BeautyFarm Med reached HK$30.5 at its debut today, representing an increase of 57.9% over the offer price.

Key Points: 
  • The stock price of BeautyFarm Med reached HK$30.5 at its debut today, representing an increase of 57.9% over the offer price.
  • BeautyFarm Med is the largest provider of traditional beauty services and the fourth largest non-surgical aesthetic medical service provider in China with a market share of 0.2% and 0.6%, respectively, as measured by revenue in 2021 and according to Frost & Sullivan.
  • The Company provides overall beauty and health management services through its well-established and widely recognized brand portfolio of BeautyFarm, Palaispa, CellCare and Neology.
  • The service offerings of the Company cover traditional beauty services, aesthetic medical services as well as subhealth assessment and intervention services, across the full client lifecycle.

BeautyFarm Med Announces Global Offering Results, Offer Price of HK$19.32per Share

Retrieved on: 
Friday, January 13, 2023
Trust, Language isolate, International, Motherboard, Marketing, History, Growth, Danna International (Offer Nissim Presents), Teleport Communications Group, Neology, Hong Kong Stock Exchange, Stock exchange, CCASS, Property management

The Offer Price is HK$19.32 per share.

Key Points: 
  • The Offer Price is HK$19.32 per share.
  • The Hong Kong Offer Shares initially offered under the Hong Kong Public Offering have been very significantly oversubscribed.
  • The Offer Shares initially offered under the International Offering have been moderately oversubscribed, representing approximately 4.7 times of the total number of 36,482,500 International Offer Shares initially available for subscription under the International Offering.
  • The outstanding share oversubscription shows the trust and support of global investors for the Company's business development and lays a firm ground for the Company's long-term growth.